サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1414274

造血幹細胞移植（HSCT）の世界市場レポート 2024年

Hematopoietic Stem Cell Transplantation Global Market Report 2024
出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
造血幹細胞移植（HSCT）の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 目次
概要

造血幹細胞移植（HSCT）市場規模は近年力強く成長しています。2023年の42億4,000万米ドルから2024年には46億5,000万米ドルへと、CAGR9.6％で拡大します。過去の期間に見られた拡大は、早期移植技術の開発、適応症とドナー源の限定、コンディショニングレジメンの進歩、同種移植の出現、造血幹細胞移植（HSCT）分野における規制のマイルストーンなどの要因に起因しています。

造血幹細胞移植（HSCT）市場規模は、今後数年で急成長が見込まれます。2028年にはCAGR10.1％で68億2,000万米ドルに成長します。予測期間中に予想される成長は、治療適応の拡大、ドナー供給源の多様化、個別化医療とゲノミクスの影響、規制の変更とガイドラインの更新、市場の拡大とアクセシビリティの向上に起因すると考えられます。予測期間に予想される主な動向は、移植技術の進歩、治療適応の拡大、細胞療法の出現、ドナープールの多様化、造血幹細胞移植（HSCT）における精密医療アプローチの採用などです。

予測される血液がんの発生急増は、造血幹細胞移植（HSCT）市場の成長を促進します。血液がんには、白血病、リンパ腫、骨髄腫など、血液細胞の発達や機能に影響を及ぼす悪性腫瘍の一群が含まれます。造血幹細胞移植（HSCT）は、これらの疾患に対する一般的な治療法であり、悪性腫瘍によって損傷を受けた幹細胞や骨髄細胞の置換を伴う。移植された幹細胞は骨髄に移動し、新しい血液細胞の生産を開始します。2022年8月、英国血液がん協会（Blood Cancer UK）は、英国で年間41,000人の血液がん患者が確認されたと報告しました。2022年には500人以上の小児を含む250,000人が罹患すると推定され、血液がんの罹患率の増加が造血幹細胞移植（HSCT）市場を牽引しています。

高齢化人口の急増は、造血幹細胞移植（HSCT）市場の成長に寄与すると予想されます。65歳以上と定義される高齢化人口は、造血幹細胞移植（HSCT）を様々な血液疾患の有効な治療法として見出しています。顕著な例として、世界保健機関（WHO）は、2030年までに世界の6人に1人が60歳以上になり、その数は2050年までに21億人に倍増すると予測しています。英国では、2043年までに総人口の24％（1,740万人）が高齢者になると予想されています。その結果、高齢化人口の拡大が造血幹細胞移植（HSCT）市場を牽引することになります。

2023年の造血幹細胞移植（HSCT）市場で最大の地域は北米でした。アジア太平洋は、予測期間中、世界の造血幹細胞移植（HSCT）市場で最も急成長している地域になると予想されています。造血幹細胞移植（HSCT）市場レポートの対象地域は、アジア太平洋、西欧、東欧、北米、南米、中東・アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 市場促進要因・市場抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 市場規模と成長実績、2018～2023年
  • 市場規模と成長予測、2023～2028年、2033年

第6章 市場セグメンテーション

  • 世界の造血幹細胞移植（HSCT）市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 同種
  • 自家
  • 世界の造血幹細胞移植（HSCT）市場、適応症別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 白血病
  • リンパ系疾患
  • 骨髄腫
  • その他
  • 世界の造血幹細胞移植（HSCT）市場、用途別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 骨髄移植
  • 末梢血幹細胞移植
  • 臍帯血移植
  • 世界の造血幹細胞移植（HSCT）市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • 専門クリニック

第7章 地域および国の分析

  • 世界の造血幹細胞移植（HSCT）市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の造血幹細胞移植（HSCT）市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 造血幹細胞移植（HSCT）市場の競合情勢
  • 造血幹細胞移植（HSCT）市場企業プロファイル
    • Pluristem Therapeutics Inc.
    • Lonza Group AG
    • Escape Therapeutics Inc
    • Regen Biopharma Inc.
    • Bluebird Bio Inc

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r11784

“Hematopoietic Stem Cell Transplantation Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on hematopoietic stem cell transplantation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for hematopoietic stem cell transplantation? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The hematopoietic stem cell transplantation market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Type: Allogeneic; Autologous
  • 2) By Indication: Leukemia; Lymphatic Disorder; Myeloma; Other Non-Malignant Disorders
  • 3) By Application: Bone Marrow Transplant; Peripheral Blood Stem Cell Transplant; Cord Blood Transplant
  • 4) By End User: Hospital Pharmacy; Retail Pharmacy; Specialty Clinics
  • Companies Mentioned: Pluristem Therapeutics Inc.; Lonza Group AG; Escape Therapeutics Inc.; Regen Biopharma Inc.; Bluebird Bio Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Hematopoietic stem cell transplantation (HSCT) is a medical procedure employed to treat diverse blood and bone marrow disorders, including certain genetic conditions and autoimmune diseases. The process entails replacing a patient's damaged or diseased bone marrow with healthy stem cells obtained from a donor. These transplanted stem cells then grow and generate new blood cells within the patient's body. The stem cells for transplantation can be sourced from bone marrow, peripheral blood, or umbilical cord blood.

The primary types of cells used in hematopoietic stem cell transplantation are allogeneic and autologous. Allogeneic transplants involve stem cells obtained from a donor with a different genetic makeup than the recipient. This type of transplantation is applied to address conditions such as leukemia, lymphatic disorders, myeloma, and others. The applications include bone marrow transplants, peripheral blood stem cell transplants, and cord blood transplants. Hematopoietic stem cell transplantation is utilized by various end-users, including hospital pharmacies, retail pharmacies, and specialty clinics.

The hematopoietic stem cell transplantation market research report is one of a series of new reports from The Business Research Company that provides hematopoietic stem cell transplantation market statistics, including hematopoietic stem cell transplantation industry global market size, regional shares, competitors with a hematopoietic stem cell transplantation market share, detailed hematopoietic stem cell transplantation market segments, market trends and opportunities, and any further data you may need to thrive in the hematopoietic stem cell transplantation industry. This hematopoietic stem cell transplantation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The hematopoietic stem cell transplantation market size has grown strongly in recent years. It will grow from $4.24 billion in 2023 to $4.65 billion in 2024 at a compound annual growth rate (CAGR) of 9.6%. The expansion observed in the historical period can be attributed to factors such as the development of early transplantation techniques, limited indications and donor sources, advancements in conditioning regimens, the emergence of allogeneic transplants, and regulatory milestones in the field of hematopoietic stem cell transplantation.

The hematopoietic stem cell transplantation market size is expected to see rapid growth in the next few years. It will grow to $6.82 billion in 2028 at a compound annual growth rate (CAGR) of 10.1%. The anticipated growth in the forecast period can be attributed to expanded treatment indications, diversification of donor sources, the influence of personalized medicine and genomics, regulatory changes and updated guidelines, and increased market expansion and accessibility. Key trends expected in the forecast period encompass advancements in transplant techniques, a broader range of treatment indications, the emergence of cellular therapies, a more diverse donor pool, and the adoption of a precision medicine approach in hematopoietic stem cell transplantation.

The anticipated surge in the occurrence of blood cancer is set to drive the growth of the hematopoietic stem cell transplantation market. Blood cancers encompass a group of malignancies affecting the development and functioning of blood cells, including leukemia, lymphoma, and myeloma. Hematopoietic stem cell transplantation is a common treatment for these conditions, involving the replacement of stem cells and bone marrow cells damaged by the malignancy. These transplanted stem cells migrate to the bone marrow, initiating the production of new blood cells. In August 2022, Blood Cancer UK reported 41,000 identified blood cancer cases annually in the UK, making it the sixth most prevalent cancer. With an estimated 250,000 people affected in 2022, including over 500 children, the increased incidence of blood cancer drives the hematopoietic stem cell transplantation market.

The burgeoning aging population is expected to contribute to the growth of the hematopoietic stem cell transplantation market. The aging population, defined as individuals aged 65 and older, finds hematopoietic stem cell transplantation a viable treatment for various hematological disorders. As a notable example, the World Health Organization projected that globally, one in six people would be 60 or older by 2030, with the number doubling to 2.1 billion by 2050. In the UK, it is anticipated that by 2043, 24% of the total population (17.4 million people) will be seniors. Consequently, the expanding aging population propels the hematopoietic stem cell transplantation market.

Product approvals emerge as a prominent trend in the hematopoietic stem cell transplantation market, with major companies securing regulatory clearances to sustain their market positions. For instance, in April 2022, Ireland-based Priothera Ltd. received FDA clearance for an investigational new drug (IND) to initiate a Phase IIb/III research study with mocravimod in acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplant. Mocravimod, a synthetic sphingosine 1-phosphate receptor (S1PR) modulator, demonstrated safety and efficacy in earlier trials for various autoimmune diseases.

Major companies in the hematopoietic stem cell transplantation industry are adopting a strategic partnership approach to accelerate research and development through complementary strengths. In July 2021, US-based biotech company Vor Biopharma collaborated with Belgium-based Janssen Pharmaceutical to develop engineered hematopoietic stem cell transplants (eHSCTs) combined with a bi-specific antibody therapy for acute myeloid leukemia (AML). This partnership aims to broaden the application of eHSCT-based therapies to other cancers and blood disorders.

In August 2022, France-based Eurobio Scientific Group acquired Netherlands-based Genome Diagnostics B.V. for $132.3 million, enhancing Eurobio's commercial portfolio for evaluating compatibility in organ and marrow transplants, further solidifying its position in the hematopoietic stem cell transplantation market.

Major companies operating in the hematopoietic stem cell transplantation market report are Pluristem Therapeutics Inc., Lonza Group AG, Escape Therapeutics Inc., Regen Biopharma Inc., Bluebird Bio Inc., CellGenix GmbH, CBR Systems Inc., Merck KGaA, Cord Blood Corporation, Kiadis Pharma NV, Marker Therapeutics Inc., Taiga Biotechnologies Inc., Takeda Pharmaceutical Company Limited, Talaris Therapeutics Inc., ViaCord LLC, ScienCell Research Laboratories Inc., BiolineRx, Stemcell Technologies Inc., ThermoGenesis Holdings Inc., MEDIPOST Co. Ltd., Anterogen. Co. Ltd., Pharmicell Inc., NuVasive Inc., RTI Surgical Ltd., JCR Pharmaceuticals Co. Ltd., Holostem Terapie Avanzate Srl, Regrow Biosciences Pvt Ltd., Stempeutics Research Pvt Ltd., 3D Biomatrix, Worthington Biochemical

North America was the largest region in the hematopoietic stem cell transplantation market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global hematopoietic stem cell transplantation market during the forecast period. The regions covered in the hematopoietic stem cell transplantation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the hematopoietic stem cell transplantation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The hematopoietic stem cell transplantation (HSCT) market includes revenues earned by entities providing services such as medical evaluation, pre-transplant care, stem cell collection and processing, transplantation procedures, post-transplant care, supportive care, and long-term follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Hematopoietic Stem Cell Transplantation Market Characteristics

3. Hematopoietic Stem Cell Transplantation Market Trends And Strategies

4. Hematopoietic Stem Cell Transplantation Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Hematopoietic Stem Cell Transplantation Market Size and Growth

  • 5.1. Global Hematopoietic Stem Cell Transplantation Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Hematopoietic Stem Cell Transplantation Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Hematopoietic Stem Cell Transplantation Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Hematopoietic Stem Cell Transplantation Market Segmentation

  • 6.1. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Allogeneic
  • Autologous
  • 6.2. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Leukemia
  • Lymphatic Disorder
  • Myeloma
  • Other Non-Malignant Disorders
  • 6.3. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Bone Marrow Transplant
  • Peripheral Blood Stem Cell Transplant
  • Cord Blood Transplant
  • 6.4. Global Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacy
  • Retail Pharmacy
  • Specialty Clinics

7. Hematopoietic Stem Cell Transplantation Market Regional And Country Analysis

  • 7.1. Global Hematopoietic Stem Cell Transplantation Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Hematopoietic Stem Cell Transplantation Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Hematopoietic Stem Cell Transplantation Market

  • 8.1. Asia-Pacific Hematopoietic Stem Cell Transplantation Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Hematopoietic Stem Cell Transplantation Market

  • 9.1. China Hematopoietic Stem Cell Transplantation Market Overview
  • 9.2. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Hematopoietic Stem Cell Transplantation Market

  • 10.1. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Hematopoietic Stem Cell Transplantation Market

  • 11.1. Japan Hematopoietic Stem Cell Transplantation Market Overview
  • 11.2. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Hematopoietic Stem Cell Transplantation Market

  • 12.1. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Hematopoietic Stem Cell Transplantation Market

  • 13.1. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Hematopoietic Stem Cell Transplantation Market

  • 14.1. South Korea Hematopoietic Stem Cell Transplantation Market Overview
  • 14.2. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Hematopoietic Stem Cell Transplantation Market

  • 15.1. Western Europe Hematopoietic Stem Cell Transplantation Market Overview
  • 15.2. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Hematopoietic Stem Cell Transplantation Market

  • 16.1. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Hematopoietic Stem Cell Transplantation Market

  • 17.1. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Hematopoietic Stem Cell Transplantation Market

  • 18.1. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Hematopoietic Stem Cell Transplantation Market

  • 19.1. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Hematopoietic Stem Cell Transplantation Market

  • 20.1. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Hematopoietic Stem Cell Transplantation Market

  • 21.1. Eastern Europe Hematopoietic Stem Cell Transplantation Market Overview
  • 21.2. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Hematopoietic Stem Cell Transplantation Market

  • 22.1. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Hematopoietic Stem Cell Transplantation Market

  • 23.1. North America Hematopoietic Stem Cell Transplantation Market Overview
  • 23.2. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Hematopoietic Stem Cell Transplantation Market

  • 24.1. USA Hematopoietic Stem Cell Transplantation Market Overview
  • 24.2. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Hematopoietic Stem Cell Transplantation Market

  • 25.1. Canada Hematopoietic Stem Cell Transplantation Market Overview
  • 25.2. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Hematopoietic Stem Cell Transplantation Market

  • 26.1. South America Hematopoietic Stem Cell Transplantation Market Overview
  • 26.2. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Hematopoietic Stem Cell Transplantation Market

  • 27.1. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Hematopoietic Stem Cell Transplantation Market

  • 28.1. Middle East Hematopoietic Stem Cell Transplantation Market Overview
  • 28.2. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Hematopoietic Stem Cell Transplantation Market

  • 29.1. Africa Hematopoietic Stem Cell Transplantation Market Overview
  • 29.2. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Hematopoietic Stem Cell Transplantation Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Hematopoietic Stem Cell Transplantation Market Competitive Landscape And Company Profiles

  • 30.1. Hematopoietic Stem Cell Transplantation Market Competitive Landscape
  • 30.2. Hematopoietic Stem Cell Transplantation Market Company Profiles
    • 30.2.1. Pluristem Therapeutics Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Lonza Group AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Escape Therapeutics Inc
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Regen Biopharma Inc.
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Bluebird Bio Inc
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Hematopoietic Stem Cell Transplantation Market Competitive Benchmarking

32. Global Hematopoietic Stem Cell Transplantation Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Hematopoietic Stem Cell Transplantation Market

34. Hematopoietic Stem Cell Transplantation Market Future Outlook and Potential Analysis

  • 34.1 Hematopoietic Stem Cell Transplantation Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Hematopoietic Stem Cell Transplantation Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Hematopoietic Stem Cell Transplantation Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer